Rachael White and Graham Blakey are pleased to announce the launch of PharmaKinetic Ltd. We are ready to support your projects using our PK and clinical pharmacology expertise to unlock your drug's potential. Between them Rachael and Graham have over 40 years of drug development experience PharmaKinetic has core competency in the application of
Medical research into COVID-19 is mainly focused on two general areas. Development of a vaccine and evaluation of drugs to treat the major symptoms of the disease. Much of the latter work has involved the repurposing of existing drugs. For these licensed drugs the challenge is determining the therapeutic dose necessary to treat COVID-19.
Over two-thirds of women receive prescription drugs while pregnant. These may be for pre-exisiting medical conditions or sysmptoms arising as a result of pregnancy. Most often, the advice is to avoid the use of medicines during pregnancy and breastfeeding. Changes in maternal physiology as a result of pregnancy affect the disposition of any administered
